wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37852717-071829E9-AC80-4B58-9746-A4A7DA4331CC
Q37852717-071829E9-AC80-4B58-9746-A4A7DA4331CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37852717-071829E9-AC80-4B58-9746-A4A7DA4331CC
Safety of omalizumab in asthma.
P2860
Q37852717-071829E9-AC80-4B58-9746-A4A7DA4331CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37852717-071829E9-AC80-4B58-9746-A4A7DA4331CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a87fbd76f035edd3e0cfebf36ed33f7fbf65e029
P2860
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.